About FORTA BIO INC
Forta Bio is a private, California-based biotech company developing ODC™ (Oligonucleotide-Dependent Cytotoxicity), a novel therapeutic class designed to selectively eliminate pathogenic cells while preserving healthy immunity. The company focuses on oncology, autoimmune disease, and aptamer-targeted delivery, with a platform supported by advanced AI-driven optimization and high-throughput screening.
Development of ODC™ (Oligonucleotide-Dependent Cytotoxicity) therapeuticsDual specificity and dual mechanism of action in a single synthetic oligonucleotideAptamer-targeted delivery for tissue-specific therapeutic deliveryAI-driven optimization of ODC libraries via FortaGuideAIFormulation-free delivery through scavenger receptor uptakeFocus on high-burden, underserved conditions, particularly affecting women and children
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to FORTA BIO INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.